CETAPHIL
-
octocrylene and
avobenzone lotion
Galderma Laboratories, L.P.
----------
Cetaphil® Daily Facial MoisturizerAvobenzone 3%
Octocrylene 10%
Avobenzone..........Sunscreen
Octocrylene..........Sunscreen
Filters out the sun's harmful rays to help prevent:
For external use only, not to be swallowed
When using this product
Stop use and ask a doctor if
If swallowed, get medical help or contact a Poison Control Center right away.
Water, Diisopropyl Adipate, Cyclomethicone, Glycerin, Glyceryl Stearate, PEG-100 Stearate, Polymethyl Methacrylate, Phenoxyethanol, Benzyl Alcohol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Tocopheryl Acetate, Carbomer 940, Disodium EDTA, Triethanolamine
Cetaphil®
Every Age. Every Stage. Every Day.®
Daily Facial
Moisturizer
SPF15
FOR ALL SKIN TYPES
Non-comedogenic
Lightweight, non-greasy
Fragance free
UVA/UVB Protection
4 FL OZ (118 mL)
GALDERMA
This light, non-greasy moisturizer nourishes and hydrates your skin while also protecting it from the sun's harmful rays.
Restores and improves your skin's ability to retain vital moisture.
Non-comedogenic
PABA free / Fragrance free
Dermatologist recommended
DIRECTIONS: Apply daily to face and neck, away from eyes.
Importance of daily sunscreen protection:
UV rays from the sun are made of UVA and UVB. It is important to protect against both UVA and UVB to prevent sunburn and other skin damage.
Use in conbination with a complete regimen of Cetaphil® Cleansers and Moisturizers for you daily skin care needs.
Marketed by:
Galderma Laboratories, L.P.
Fort Worth, Texas 76177 USA
GALDERMA is a registered trademark
Made in Canada
cetaphil.com
P50935-2
Cetaphil®
Daily Facial
Moisturizer
SPF15
UVA/UVB Protection
Non-comedogenic
.25 FL OZ (7 mL)
USE: Sunscreen
ACTIVE INGREDIENTS:
AVOBENZONE 3%,
OCTOCRYLENE 10%
DIRECTIONS: Apply daily to face and neck, away from eyes.
Marketed by:
Galderma® Laboratories, L.P.
Fort Worth, Texas 76177 USA
Made in Canada
cetaphil.com
SAMPLE, NOT FOR SALE
P50928-2
CETAPHIL
octocrylene, avobenzone lotion |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part352 | 04/01/2000 |
Labeler - Galderma Laboratories, L.P. (047350186) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Galderma Production Canada Inc | 251676961 | MANUFACTURE |